The Gold Standard is a workplace- based program that focuses on lowering the risk of cancer.
The Life Sciences Consortium (LSC) brings together oncology companies to accelerate discovery and development of new therapies for all cancer patients. Visit Website
President George HW Bush appointed Chris Viehbacher Chairman of the CEO Roundtable on Cancer in 2011.
Chris most recently was the Chief Executive Officer of Sanofi and Chairman of Genzyme. Prior to that in 2008, he served in a variety of global, executive positions with GlaxoSmithKline (GSK). In 2003, while serving as General Manager of GSK France, he was made a Knight of the French Legion of Honor, the highest decoration in France.
In 2012, Chris received the Pasteur Foundation Award in recognition of his leadership role in health. He has served as Chairman of the Pharmaceutical Research and Manufacturers of America and as President of the European Federation of Pharmaceutical Industries and Associations.
Chris has also served as a member of the International Business Council of the World Economic Forum and of The Business Roundtable; and on the Board of Directors of Research America and the Burroughs Wellcome Fund.
Chris is married with three children. He fluently speaks English, French and German.